Thesis Topic: Market Analysis of Digital Biomarker Companies in Diabetes Prevention

We invite motivated masters students in a dynamic research project focused on analyzing the market landscape of digital biomarker companies that aim to prevent diabetes. This research will explore how startups leverage new wearable technologies and personalized analytics, to drive forward innovation in diabetes prevention.

Project Overview

In this project, the student will conduct a market analysis of companies developing digital biomarkers for diabetes prevention. You will investigate how these startups use clinical trial data to validate their products and claims, and assess their strategies for gaining competitive advantages in a rapidly evolving health tech space. The findings will shed light on current market trends and the potential for these companies to influence the future of diabetes care.

Key Responsibilities

  • Conduct an in-depth market analysis of digital biomarker startups focused on diabetes prevention.
  • Evaluate how companies use clinical trial data to support their scientific claims and product efficacy.
  • Identify trends, challenges, and opportunities in the market, including regulatory hurdles and competitive strategies.
  • Collaborate with your thesis supervisor and the CSS Health Lab research team to provide actionable insights for business and healthcare innovation.

Who Should Apply?

This project is ideal for students interested in digital health, business strategy, or health innovation. Strong research skills, a keen interest in the business side of healthcare, and an understanding of clinical trials are highly valued. Interested students should submit a brief statement of interest and their CV to Dr. Mia Jovanova (mia.jovanova@unisg.ch). We welcome students from diverse academic disciplines, including business, healthcare, and data science.

This is a unique opportunity to explore the role of data-driven claims in shaping the future of diabetes prevention and to contribute to impactful healthcare business innovations. Join us in advancing the field of digital biomarkers and personalized diabetes prevention!

Share this post